Condor Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,600
| Closed | -$26K | – | 390 |
|
|
2022
Q3 | $26K | Buy |
2,600
+800
| +44% | +$8K | ﹤0.01% | 350 |
|
|
2022
Q2 | $18K | Sell |
1,800
-800
| -31% | -$8K | ﹤0.01% | 371 |
|
|
2022
Q1 | $26K | Hold |
2,600
| – | – | ﹤0.01% | 315 |
|
|
2021
Q4 | $26K | Hold |
2,600
| – | – | ﹤0.01% | 284 |
|
|
2021
Q3 | $26K | Hold |
2,600
| – | – | ﹤0.01% | 250 |
|
|
2021
Q2 | $27K | Hold |
2,600
| – | – | ﹤0.01% | 247 |
|
|
2021
Q1 | $26K | Buy |
+2,600
| New | +$26K | ﹤0.01% | 240 |
|